Skandinaviska Enskilda Banken Ab (Publ) Takeda Pharmaceutical CO LTD Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$16.71 - $19.9 $84,118 - $100,176	-5,034 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$15.39 - $18.97 $32,534 - $40,102	-2,114 Reduced 29.57%	5,034 $92,000
Q1 2020 Jun 05, 2020	BUY	$13.02 - $20.31 $93,066 - $145,175	7,148 New	7,148 $108,000
Q1 2020 May 13, 2020	SELL	$13.02 - $20.31 $93,066 - $145,175	-7,148 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $25,488 - $31,453	-1,510 Reduced 17.44%	7,148 $141,000
Q2 2019 Aug 09, 2019	BUY	$16.58 - $20.49 $143,549 - $177,402	8,658 New	8,658 $153,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.